vTv Therapeutics Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
vTv Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2014 to Q2 2024.
  • vTv Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
  • vTv Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $100K.
  • vTv Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000, a 100% decline from 2022.
  • vTv Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $200K, a 73.9% increase from 2021.
  • vTv Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $115K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $100K $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $100K $100K +$100K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $0 $0 $0 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $0 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $0 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $0 $0 -$200K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $200K $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $200K $0 -$100K -100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $300K $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $300K $200K +$185K +1233% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $115K $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $115K $100K +$100K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $15K $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $15K $15K +$15K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $0 $0 Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $0 -$100K -100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q2 2019 $100K -$100K -50% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q2 2018 $1M $200K +$200K Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $800K $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $800K $800K +$800K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $0 $0 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $0 $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $0 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $0 $0 Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $0 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q3 2015 $0 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-13
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.